spacer
The Healthcare Sales & Marketing Network celebrates 23 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  antibiotic resistance 

 HSMN NewsFeed - 20 Jul 2021
First Light Diagnostics Receives FDA Clearance for its Rapid Clostridiodes difficile Test on the MultiPath(R) Analyzer
Diagnostics FDA
 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 15 Dec 2020
MinervaX raises upsized EUR 47.4M (USD 57M) Series B to advance its novel Group B Streptococcus vaccine through mid-stage clinical trials
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 25 Sep 2020
Study Reveals Blood-Based Host Response Test Can Accurately Predict Respiratory Viral Infection in Pre-Symptomatic Patients
Diagnostics
 HSMN NewsFeed - 15 Jun 2020
Aridis Pharmaceuticals Appoints Dr. Hasan Jafri as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2020
SutroVax Appoints Andrew Guggenhime as Chief Financial Officer and Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Mar 2020
SutroVax Announces $110M Series D Financing to Advance Broadest-Spectrum Pneumococcal Vaccine Candidates to Prevent Pneumonia
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 23 Mar 2020
Accelerated Road to Market Approval for CERAMENT(R) G in the US - BONESUPPORT(TM) Submits De Novo Application
Devices Orthopaedic Drug Delivery FDA
 HSMN NewsFeed - 10 Jan 2020
Inflammatix Announces $32 Million in Series C Funding
Diagnostics Venture Capital
 HSMN NewsFeed - 4 Dec 2019
Accelerate Diagnostics Announces Executive Transition: Lawrence Mehren to Retire as Chief Executive Officer; Jack Phillips Appointed as Successor
Diagnostics Personnel
 HSMN NewsFeed - 11 Nov 2019
Allergan Receives FDA Qualified Infectious Disease Product (QIDP) Designation And Fast Track Designation For ATM-AVI (Aztreonam And Avibactam) For Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2019
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
Diagnostics Personnel
 HSMN NewsFeed - 25 Oct 2019
Microbion Corporation Announces Generic Name for Lead Antimicrobial Compound: Pravibismane
Biopharmaceuticals Generics
 HSMN NewsFeed - 10 Jun 2019
Aridis Pharmaceuticals Appoints Dr. Susan Windham-Bannister to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Apr 2019
Arc Bio Unveils its Galileo(TM) Pathogen Solution: A Fully Integrated NGS-based Metagenomics Platform with a Revolutionized Design for Pathogen Detection
Diagnostics Product Launch
 HSMN NewsFeed - 22 Mar 2019
Bruker Announces Improved Assay for Tuberculosis Diagnostics in Novel Liquid Array(TM) Format for Improved Multiplexing
Diagnostics Product Launch
 HSMN NewsFeed - 25 Oct 2018
Abbott Introduces the Next Generation of Influenza A & B and Strep A Assays with Fastest-Ever Time to Molecular Results
Diagnostics FDA Product Launch
 HSMN NewsFeed - 17 Sep 2018
U.S. FDA Clears Sebacia Microparticles for the Treatment of Mild to Moderate Inflammatory Acne
Devices Dermatology FDA
 HSMN NewsFeed - 30 Aug 2018
Steripath Gen2, Next Generation Initial Specimen Diversion Device, Offers An Advanced Approach to Virtually Eliminating Blood Culture Contamination
Devices Product Launch
 HSMN NewsFeed - 24 Aug 2018
Bruker Announces Agreement to Acquire Majority in Infectious Disease-focused Molecular Diagnostics (MDx) Company Hain Lifescience GmbH
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 24 May 2018
BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance
Diagnostics Product Launch
 HSMN NewsFeed - 2 Feb 2018
FDA Approves AVYCAZ(R) (ceftazidime and avibactam) for the Treatment of Patients with Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 19 Dec 2017
Inflammatix Announces Appointment of Oliver Liesenfeld, M.D., as Chief Medical Officer
Diagnostics Personnel
 HSMN NewsFeed - 2 Aug 2017
Collidion Acquires 80% Stake in Plex Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Feb 2017
Accelerate Diagnostics Receives FDA Marketing Authorization for the Accelerate Pheno(TM) System and Accelerate PhenoTest(TM) BC Kit
Diagnostics FDA
 HSMN NewsFeed - 22 Dec 2016
Lancet Infectious Diseases Publishes Independent Double-Blind Study Validating MeMed's Immunoxpert(TM) Blood Test's Ability to Accurately Distinguish Between Bacterial and Viral Infections in Children
Diagnostics
 HSMN NewsFeed - 7 Sep 2016
FDA Grants Special Designation to TAXIS Pharmaceuticals Experimental Antibiotic
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Jul 2016
SinuSys(TM) Corp. Receives FDA Clearance for the Vent-Os(R) Sinus Dilation Family of Devices
Devices FDA
 HSMN NewsFeed - 15 Jun 2016
Allecra Therapeutics Announces €22 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Mar 2016
Kris Peterson to Join Paratek Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Feb 2016
Spero Therapeutics Announces $30 Million Series B Preferred Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Jan 2016
Allergan Announces Collaboration with AstraZeneca to Develop and Commercialize ATM-AVI (aztreonam and avibactam) for Antibiotic-Resistant Gram-Negative Infections
Biopharmaceuticals Licensing Distribution
 HSMN NewsFeed - 13 Jan 2016
Epistem Appoints David Budd as Chief Executive Officer
Diagnostics Personalized Medicine Personnel
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 5 Dec 2014
Basilea Announces Launch of Antibiotic Zevtera(R) (ceftobiprole medocaril) in Germany
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Sep 2014
Synereca Pharmaceuticals Announces Financing Led by Accele Venture Partners
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2014
NovaBiotics Receives Orphan Drug Status from the US Food and Drug Administration (FDA) for Lynovex(R) for the Treatment of Cystic Fibrosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 1 Jul 2014
Paratek Appoints Michael Bigham as Chairman and CEO and Promotes Evan Loh to President and CMO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2014
Gentle, Simple SinuSys(TM) Vent-Os(TM) Sinus Dilation System Obtains FDA Clearance
Devices FDA
 HSMN NewsFeed - 30 Dec 2013
Cubist Announces FDA Acceptance of Tedizolid New Drug Application with Priority Review
Biopharmaceuticals FDA
 HSMN NewsFeed - 24 Dec 2013
AmpliPhi Biosciences Closes $18 Million Private Placement
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Nov 2013
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2013
Arsanis Inc Closes $20 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Apr 2013
New Anti-Infectives Company, Allecra Therapeutics, Created With €15 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2013
BONESUPPORT Announces CE Mark and Launch of CERAMENT(TM) G, the First Injectable Gentamicin Eluting Bone Substitute To Promote and Protect Bone Healing in Osteomyelitis
Devices Orthopaedic Regulatory Product Launch
 HSMN NewsFeed - 22 May 2012
Paratek Announces Appointments of Dennis Molnar as Chief Executive Officer and Director and of Dr. Evan Loh as Chief Medical Officer and Chairman of the Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Apr 2011
Durata Therapeutics Initiates Phase 3 Study of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 14 Apr 2011
Mpex Pharmaceuticals, Inc. to be Acquired by Axcan
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Feb 2011
Arsanis, Inc Announces Series A Financing with OrbiMed Advisors, Polaris Venture Partners and SV Life Sciences
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Jun 2010
Tetraphase Closes $45 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 Mar 2010
FDA Accepts Filing of Ondine's Pre-Market Approval (PMA) Application for Periowave(TM) Photodisinfection System
Devices Dental FDA
 HSMN NewsFeed - 13 Jan 2010
AstraZenenca and CrystalGenomics, Inc. Form Research Collaboration to Develop Novel Anti-Infective Treatments
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2010
Ondine Files PMA Submission for Periowave(TM) Photodisinfection System
Devices Dental FDA
 HSMN NewsFeed - 23 Nov 2009
Inimex Announces Appointment of New CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2009
Paratek Pharmaceuticals Signs Worldwide License and Commercialization Agreement for PTK 0796, Broad-Spectrum Oral and IV Antibiotic in Phase 3
Biopharmaceuticals Licensing
 HSMN NewsFeed - 16 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tony Zook of MedImmune to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2009
Forest Laboratories UK Ltd Submits Marketing Authorisation Application for the First Dry Powder Inhalation Antibiotic for Cystic Fibrosis Patients
Biopharmaceuticals
 HSMN NewsFeed - 4 Sep 2009
Rib-X Pharmaceuticals, Inc. Appoints Tom Kassberg Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2009
Forest Laboratories and AstraZeneca to Co-Develop and Commercialize a Late Stage Next Generation Anti-Infective
Biopharmaceuticals
 HSMN NewsFeed - 14 May 2009
Cempra Pharmaceuticals Closes $46 Million Series C Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 May 2009
AdvanDx Receives FDA 510(k) Clearance for EK/P. aeruginosa PNA FISH(R)
Diagnostics FDA
 HSMN NewsFeed - 20 Apr 2009
Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 Mar 2009
FDA Approves New Indication for Wyeth's TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2009
Mpex Pharmaceuticals Announces Series D Financing of Up to $40 Million
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Feb 2009
Minocycline/Rifampin-Impregnated Catheters Proven Clinically Effective in Preventing and Combating Potentially Fatal Bloodstream Infections in Two New Studies
Devices
 HSMN NewsFeed - 30 Jan 2009
AdvanDx Receives FDA 510(k) Clearance for E. coli/P. aeruginosa PNA FISH(R)
Diagnostics FDA
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Oct 2008
Advanced Life Sciences and Wyeth Sign Commercialization Agreement for Cethromycin in Asia Pacific Region
Biopharmaceuticals
 HSMN NewsFeed - 29 Sep 2008
Cepheid Receives FDA Clearance for First Rapid On-Demand Molecular Diagnostic Test for MRSA and S. aureus
Diagnostics FDA
 HSMN NewsFeed - 3 Sep 2008
Rib-X Pharmaceuticals, Inc. Appoints Dr. Joseph Amprey of MedImmune Ventures to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2008
Terrace Ventures Announces Proposed Business Combination
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 19 Jun 2008
Forest Laboratories Announces Positive Results from Phase III Clinical Studies of Ceftaroline for the Treatment of Complicated Skin and Skin Structure Infections
Biopharmaceuticals
 HSMN NewsFeed - 16 Jun 2008
GlaxoSmithKline and Mpex Pharmaceuticals Form Alliance to Develop Novel Efflux Pump Inhibitors for Use Against Serious Gram-Negative Infections
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2008
Gilead Announces Interim 12-Month Phase III Study Results for Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
Biopharmaceuticals
 HSMN NewsFeed - 4 Jun 2008
Protez Pharmaceuticals to Be Acquired by Novartis
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 6 May 2008
Rib-X Pharmaceuticals, Inc. Appoints Nancy Motola as Senior Vice President of Regulatory Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2008
American Academy of Dermatology Research Confirms Genetic Skin Barrier Defect Linked to Eczema
Dermatology
 HSMN NewsFeed - 24 Jan 2008
Ash Access Technology, Inc. Completes Patient Enrollment in AZEPTIC Trial for Zuragen(R)
Biopharmaceuticals Devices
 HSMN NewsFeed - 22 Jan 2008
NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA
Biopharmacuticals
 HSMN NewsFeed - 17 Dec 2007
Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Devices
 HSMN NewsFeed - 24 Oct 2007
FDA Accepts Wyeth's Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
Biopharmaceuticals
 HSMN NewsFeed - 9 Oct 2007
Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
Devices FDA
 HSMN NewsFeed - 8 Oct 2007
Dade Behring Receives FDA Clearance for Rapid-Result Gram Positive Microbiology Tests
Diagnostics FDA
 HSMN NewsFeed - 24 Sep 2007
Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 17 Sep 2007
Mpex Pharmaceuticals Names Dr. Jeffery Loutit as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Aug 2007
MethylGene and Pharmion Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 21 Aug 2007
Pharmion and MethylGene Announce U.S. Orphan Drug Designation Granted for MGCD0103 for the Treatment of Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 2 Aug 2007
Obagi Medical Products' New Study Shows CLENZIderm M.D. is Clinically Effective in the Treatment of Acne at Both Once- and Twice-Daily Dosing
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 10 Jul 2007
Angiotech completes enrolment in its Central Venous Catheter (CVC) Pivotal Study
Devices
 HSMN NewsFeed - 25 Jun 2007
MicuRx Pharmaceuticals Completes $10 Million Series A Financing to Fund Discovery and Development of Next-Generation Antibiotics
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Jun 2007
FDA Approves Differin(R) (adapalene) Gel, 0.3% for Acne
Biopharmaceuticals Dermatology FDA
 HSMN NewsFeed - 2 Jun 2007
Pharmion and MethylGene Report Preliminary Data for MGCD0103 at the 43rd American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 Apr 2007
GSK Announces FDA Approval of Altabax(TM) (Retapamulin Ointment), 1%
Biopharmaceuticals FDA
 HSMN NewsFeed - 17 Jan 2007
Cepheid and bioMerieux Enter Into Strategic Agreements to Develop and Market Sepsis and MRSA Products
Diagnostics
 HSMN NewsFeed - 8 Jan 2007
SkinMedica Launches NeoBenz(R) Micro SD for Acne
Biopharmaceuticals Dermatology Drug Delivery
 HSMN NewsFeed - 11 Oct 2006
Immtech Pharmaceuticals Announces Antimicrobial Pipeline Progress
Biopharmaceuticals
 HSMN NewsFeed - 2 Oct 2006
Ash Access Technology, Inc. Investigational Antimicrobial / Antithrombotic Therapy (Zuragen(TM)) Pivotal Clinical Trial Begins
Biopharmaceuticals
 HSMN NewsFeed - 16 Aug 2006
Cempra Pharmaceuticals Raises $14 Million Round of Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 14 Feb 2006
GlaxoSmithKline's Topical Antibacterial Retapamulin Accepted for Review by The U.S. Food and Drug Administration
Biopharmaceuticals
 HSMN NewsFeed - 24 Jan 2006
Ash Access Technology, Inc. Announces a Private Fund Managed by Bear Stearns and Other New Investors Have Subscribed to Their $6M Series B Round of Financing
Devices Venture Capital
 HSMN NewsFeed - 5 Jan 2006
Angiotech Initiates Anti-Infective CVC U.S. Pivotal Study
Devices Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 39

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 39 additional stories matching:
antibiotic resistance
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.